The Ensuring Patient Access to Critical Breakthrough Products Act (HR 1691) would rob the US Center for Medicare and Medicaid Services of its “discretion to say no” to coverage of medical devices, a new opinion piece states.
C. Joseph Ross Daval, Liam Bendicksen and Aaron Kesselheim of Brigham and Women’s Hospital and Harvard Medical School published an article in Nature in September arguing against the Ensuring...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?